ACC issues updated guidance on cardiovascular risk reduction in type 2 diabetes patients

The American College of Cardiology has issued an expert consensus decision pathway (ECDP) to guide cardiovascular specialists in the initiation and monitoring of diabetes medications with the express goal of reducing cardiovascular risk. The document was published today in the Journal of the American College of Cardiology. Despite major therapeutic advances leading to improved outcomes, […]

Continue Reading

Medicare Part D favors generic prescription drugs over branded counterparts, study finds

Contrary to previous media reports, a new study led by Vanderbilt University Medical Center researchers finds that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts. Published this week in Health Affairs, the study led by Stacie Dusetzina, Ph.D., Ingram Associate Professor of Cancer Research and associate professor of Health […]

Continue Reading